What happened
OliX Pharmaceuticals updated the terms of a private placement (third-party allotment) to raise US$71.8M, about 4.0% of its market value.
For context, this raise equals about 4.0% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$71.8M |
| vs. market value | 4.0% |
| Filed | 2026-06-29, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260629000459 → open original filing |
Versions of this filing
- 2026-06-01Original
- 2026-06-29Amendment 1 (this page)
Source: DART. Information only, not investment advice.